Benitec Biopharma Inc. (BNTC) Revenue Growth
Benitec Biopharma Inc. (BNTC) year-over-year revenue growth rate history. Analyze revenue growth in Excel with MarketXLS.
Revenue Growth Data
| Period | YoY Revenue Growth |
|---|---|
| 2019-06-30 | N/A |
| 2020-06-30 | N/A |
| 2021-06-30 | -39.18% |
| 2022-06-30 | 23.73% |
| 2023-06-30 | 2.74% |
| 2024-06-30 | N/A |
| 2025-06-30 | N/A |
How BNTC compares with sector peers
| Symbol | Company | Revenue growth (latest fiscal year) |
|---|---|---|
| SPRO | Spero Therapeutics Inc. | 24.27% |
| NTLA | Intellia Therapeutics Inc. | 16.92% |
| VERU | Veru Inc. | 3.62% |
| RFL | Rafael Holdings Inc. Class B | -4.69% |
| EYPT | EyePoint Pharmaceuticals Inc. | -27.50% |
These are five companies in the same sector as BNTC with a comparable annual revenue growth. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Benitec Biopharma Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue_Growth("BNTC", 2025, "")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | BNTC | $9.04 | -0.55% | 0.14M |
| 3 | ||||
| 4 | ||||
| 5 |